ArticleJournal of thoracic disease2026
Recommendation-adherent systematic lymph node sampling is not associated with increased complication rates in non-small cell lung cancer surgery-combined cardiothoracic center experience.
Article in Journal of thoracic disease, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Lymph node harvesting during lung resection procedures is a crucial part of treating lung cancer. Despite medical consensus on this issue, the required and safe extent of lymph node harvesting is under debate. A competing, more conservative approach to nodal harvesting suggests that some patients may benefit from limited sampling (LS), thus avoiding complications related to more extensive nodal dissection. Our goal was to evaluate the complication rates with different lymph node sampling strategies. A retrospective single-center cohort study conducted at a combined cardiothoracic unit (n=521) was formed of patients with non-small cell lung cancer (NSCLC) that underwent lobectomy. Patients were divided into three groups based on the extent of mediastinal nodal sampling: no sampling (NS, n=89), LS (n=313) and recommendation-adherent systematic sampling (RA, n=119). Comparison was made between the three groups. The primary outcome was any postoperative complication. Complication rate was similar between the groups, overall complication 38.2% for NS, 39.6% for LS and 35.3% for RA, P=0.30. Comprehensive complication index (CCI) median 0, interquartile range (IQR) 0-20.9 in all groups, P=0.89. The number of severe complications did not differ at a statistically significant level between the groups, NS 12.4%, LS 11.2%
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.